In particular, in RKIP knockout studies, RKIP has been shown to activate RhoA, a negative regulator of breast cancer, which in turn, stabilizes E-cadherin in adherens junctions and regulates E-cadherin localization to the membrane [185]. Here, PEBP1 is linked to breast carcinoma.